🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I, open-label, single-arm, dose-escalation and expansion st...
Status
Recruiting
Location
West China Hospital, Sichuan University
Start Date
2023-02-15
Trial ID
NCT05477927
Treatments Being Tested
The primary objective of this trial is to improve the overall survival rate...
Status
Recruiting
Location
Subang Jaya Medical Centre
Start Date
2020-03-04
Trial ID
NCT06336395
Based on the pediatric-inspired, PEG-L-asparaginase-intensified and MRD-dir...
Status
Unknown
Location
Department of Hematology, Nanfang Hospital
Start Date
2016-02-14
Trial ID
NCT03564704
Treatments Being Tested
Treatment of pediatric acute lymphoblastic leukemia (ALL) has advanced and ...
Status
Unknown
Location
Seoul National University, College of Medicine
Start Date
2015-01
Trial ID
NCT02339350
Treatments Being Tested
An experimental drug called EZN-3042 targets survivin, a protein expressed ...
Status
Terminated
Location
Childrens Hospital Los Angeles
Start Date
2010-08-24
Trial ID
NCT01186328
Treatments Being Tested
A retro-prospective case-control Swiss study was conducted to evaluate the ...
Status
Completed
Location
Laurence Toutous Trellu
Start Date
2019-03-01
Trial ID
NCT06152393
An open, multi- center phase Ⅰ clinical study evaluating the safety and eff...
Status
Recruiting
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2024-11-21
Trial ID
NCT06671236
Treatments Being Tested
This study is open-label, multi-center, prospective study, which targets ch...
Status
Recruiting
Location
Kyungpook National University Chilgok Hospital
Start Date
2024-04-04
Trial ID
NCT05827549
Treatments Being Tested
The proposed study is a single arm Phase I trial aimed at treating up to 6 ...
Status
Not Yet Recruiting
Location
The University of Texas M. D. Anderson Cancer Center
Start Date
2026-08-31
Trial ID
NCT07414979
Treatments Being Tested
This research is being done to evaluate tazemetostat in combination with CH...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-12-24
Trial ID
NCT06692452
Treatments Being Tested